The effect of the anti-ageing drug rapamycin differs in male and female fruit flies, find researchers, who seek to understand how sex influences the development of age-related disease.
Paul Sommerfeld, Executive Trustee, TB Alert and Chair, TB Europe Coalition, walks us through tackling tuberculosis. We hear that while there are continuing problems, there are finally grounds for optimism.
Dr Gerard Sinovich, Lead Pain Specialist, provides an in-depth commentary on behalf of Cantourage Clinic concerning what we need to know about opioids and opioid dependence.
Efforts to prevent or treat Alzheimer’s Disease (AD) by targeting Amyloid beta (Aβ) assemblies should be continued, but the strategies should be altered dramatically.
Dr Zisis Kozlakidis directs our thoughts towards the molecular aspects of global Infection Prevention and Control, in this the second of a special two-part series.
In this interview, Abbas Kanani, MRPharmS, Superintendent Pharmacist at Chemist Click, tells us about amyloidosis, a group of rare diseases in which abnormal proteins deposit as amyloid in tissues and organs.
David Nutt FMedSci, Chair Drug Science and PAREA, Prof of Neuropsychopharmacology at Imperial College London, explains why Europe needs to catch up with psychedelic research.
Researchers discover drug combination that could offer a better prognosis for children diagnosed with MYC amplified Medulloblastoma, an often deadly form of brain cancer.
